サマリー

2型糖尿病の世界市場 2023-2027
Technavioは2型糖尿病市場を監視しており、2023年から2027年の間に393億7000万ドルの成長が見込まれ、予測期間中にCAGR10.94%で加速しています。当レポートでは、2型糖尿病市場の全体分析、市場規模・予測、トレンド、成長促進要因、課題、さらに約25社のベンダーを網羅したベンダー分析を行っています。
現在の世界市場のシナリオ、最新のトレンドとドライバー、市場全体の環境に関する最新の分析を提供しています。市場は、糖尿病の有病率の上昇、肥満の有病率の上昇とライフスタイルの変化、最近の製品承認によって牽引されています。
Technavioの2型糖尿病市場は、以下のように区分されています。
薬物クラス別
- インスリン
- DPP-4阻害剤
- GLP-1受容体アゴニスト
- SGLT-2阻害剤
- その他
販売チャネル別
- 小売薬局
- 病院薬局
- オンライン薬局
地域別
- 北アメリカ
- 欧州
- アジア
- その他の地域 (ROW)
本調査では、今後数年間における2型糖尿病市場の成長を牽引する主な要因の1つとして、高齢者人口の増加を挙げています。また、糖尿病に対する意識の高まりや、成長戦略、治療法の革新が、市場の大きな需要につながると考えられます。
Technavioは、複数のソースからのデータを調査、合成、要約し、主要パラメータの分析によって、市場の詳細な姿を提示します。2型糖尿病市場に関する当レポートの対象領域は以下の通りです。
- 2型糖尿病市場のサイジング
- 2型糖尿病市場の予測
- 2型糖尿病市場の産業分析
Technavioの強力なベンダー分析は、お客様が市場での地位を向上できるように設計されており、これに沿って本レポートでは、Amgen Inc、AstraZeneca Plc、Baxter International Inc、Biocon Ltd、Boehringer Ingelheim International GmbH、Cadila Pharmaceuticals Ltd、第一三共Inc.を含むいくつかの主要2型糖尿病市場ベンダーについての詳細分析を提供します。(注)1.本株式交換は、株式交換完全子会社の株式交換であり、株式交換完全子会社の新株予約権及び新株予約権付社債に関する取決めは ありません。武田薬品工業株式会社、武田薬品工業株式会社、東華東方製薬株式会社、東華東方製薬株式会社Ltd.、Sanofi SA、武田薬品工業株式会社、東華東方製薬株式会社また、2型糖尿病市場の分析レポートには、今後の動向や市場成長に影響を与える課題に関する情報も含まれています。これは、企業が戦略を立て、今後訪れるすべての成長機会を活用するのに役立つものです。
本調査は、業界の主要参加者からのインプットを含む一次情報および二次情報の客観的な組み合わせを使用して実施されました。本レポートには、主要ベンダーの分析に加え、包括的な市場およびベンダーランドスケープが含まれています。本レポートの詳細については、https://www.technavio.com/report/type-2-diabetes-market-industry-analysis をご覧ください。
Technavioは、利益、価格、競争、プロモーションなどの主要パラメータの分析により、複数のソースからのデータの研究、合成、総括の方法により、市場の詳細な姿を提示します。また、業界の主要なインフルエンサーを特定することにより、市場の様々な側面を提示しています。提示されるデータは、包括的で信頼性が高く、一次および二次にわたる広範な調査の結果です。Technavioの市場調査レポートは、正確な市場成長を予測するために、完全な競争環境と、定性的および定量的調査を用いた詳細なベンダー選定方法と分析を提供します。

ページTOPに戻る

目次

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary - Chart on Market Overview
o Exhibit 02: Executive Summary - Data Table on Market Overview
o Exhibit 03: Executive Summary - Chart on Global Market Characteristics
o Exhibit 04: Executive Summary - Chart on Market by Geography
o Exhibit 05: Executive Summary - Chart on Market Segmentation by Drug Class
o Exhibit 06: Executive Summary - Chart on Market Segmentation by Distribution Channel
o Exhibit 07: Executive Summary - Chart on Incremental Growth
o Exhibit 08: Executive Summary - Data Table on Incremental Growth
o Exhibit 09: Executive Summary - Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 10: Parent market
o Exhibit 11: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 12: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 13: Market segments
o 3.3 Market size 2022
o 3.4 Market outlook: Forecast for 2022-2027
o Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ billion)
o Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ billion)
o Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
o Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
• 4 Historic Market Size
o 4.1 Global type 2 diabetes market 2017 - 2021
o Exhibit 18: Historic Market Size - Data Table on Global type 2 diabetes market 2017 - 2021 ($ billion)
o 4.2 Drug class Segment Analysis 2017 - 2021
o Exhibit 19: Historic Market Size - Drug class Segment 2017 - 2021 ($ billion)
o 4.3 Distribution channel Segment Analysis 2017 - 2021
o Exhibit 20: Historic Market Size - Distribution channel Segment 2017 - 2021 ($ billion)
o 4.4 Geography Segment Analysis 2017 - 2021
o Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ billion)
o 4.5 Country Segment Analysis 2017 - 2021
o Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ billion)
• 5 Five Forces Analysis
o 5.1 Five forces summary
o Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
o 5.2 Bargaining power of buyers
o Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
o 5.3 Bargaining power of suppliers
o Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
o 5.4 Threat of new entrants
o Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
o 5.5 Threat of substitutes
o Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
o 5.6 Threat of rivalry
o Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
o 5.7 Market condition
o Exhibit 29: Chart on Market condition - Five forces 2022 and 2027
• 6 Market Segmentation by Drug Class
o 6.1 Market segments
o Exhibit 30: Chart on Drug Class - Market share 2022-2027 (%)
o Exhibit 31: Data Table on Drug Class - Market share 2022-2027 (%)
o 6.2 Comparison by Drug Class
o Exhibit 32: Chart on Comparison by Drug Class
o Exhibit 33: Data Table on Comparison by Drug Class
o 6.3 Insulin - Market size and forecast 2022-2027
o Exhibit 34: Chart on Insulin - Market size and forecast 2022-2027 ($ billion)
o Exhibit 35: Data Table on Insulin - Market size and forecast 2022-2027 ($ billion)
o Exhibit 36: Chart on Insulin - Year-over-year growth 2022-2027 (%)
o Exhibit 37: Data Table on Insulin - Year-over-year growth 2022-2027 (%)
o 6.4 DPP-4 inhibitor - Market size and forecast 2022-2027
o Exhibit 38: Chart on DPP-4 inhibitor - Market size and forecast 2022-2027 ($ billion)
o Exhibit 39: Data Table on DPP-4 inhibitor - Market size and forecast 2022-2027 ($ billion)
o Exhibit 40: Chart on DPP-4 inhibitor - Year-over-year growth 2022-2027 (%)
o Exhibit 41: Data Table on DPP-4 inhibitor - Year-over-year growth 2022-2027 (%)
o 6.5 GLP-1 receptor agonists - Market size and forecast 2022-2027
o Exhibit 42: Chart on GLP-1 receptor agonists - Market size and forecast 2022-2027 ($ billion)
o Exhibit 43: Data Table on GLP-1 receptor agonists - Market size and forecast 2022-2027 ($ billion)
o Exhibit 44: Chart on GLP-1 receptor agonists - Year-over-year growth 2022-2027 (%)
o Exhibit 45: Data Table on GLP-1 receptor agonists - Year-over-year growth 2022-2027 (%)
o 6.6 SGLT-2 inhibitors - Market size and forecast 2022-2027
o Exhibit 46: Chart on SGLT-2 inhibitors - Market size and forecast 2022-2027 ($ billion)
o Exhibit 47: Data Table on SGLT-2 inhibitors - Market size and forecast 2022-2027 ($ billion)
o Exhibit 48: Chart on SGLT-2 inhibitors - Year-over-year growth 2022-2027 (%)
o Exhibit 49: Data Table on SGLT-2 inhibitors - Year-over-year growth 2022-2027 (%)
o 6.7 Others - Market size and forecast 2022-2027
o Exhibit 50: Chart on Others - Market size and forecast 2022-2027 ($ billion)
o Exhibit 51: Data Table on Others - Market size and forecast 2022-2027 ($ billion)
o Exhibit 52: Chart on Others - Year-over-year growth 2022-2027 (%)
o Exhibit 53: Data Table on Others - Year-over-year growth 2022-2027 (%)
o 6.8 Market opportunity by Drug Class
o Exhibit 54: Market opportunity by Drug Class ($ billion)
• 7 Market Segmentation by Distribution Channel
o 7.1 Market segments
o Exhibit 55: Chart on Distribution Channel - Market share 2022-2027 (%)
o Exhibit 56: Data Table on Distribution Channel - Market share 2022-2027 (%)
o 7.2 Comparison by Distribution Channel
o Exhibit 57: Chart on Comparison by Distribution Channel
o Exhibit 58: Data Table on Comparison by Distribution Channel
o 7.3 Retail pharmacies - Market size and forecast 2022-2027
o Exhibit 59: Chart on Retail pharmacies - Market size and forecast 2022-2027 ($ billion)
o Exhibit 60: Data Table on Retail pharmacies - Market size and forecast 2022-2027 ($ billion)
o Exhibit 61: Chart on Retail pharmacies - Year-over-year growth 2022-2027 (%)
o Exhibit 62: Data Table on Retail pharmacies - Year-over-year growth 2022-2027 (%)
o 7.4 Hospital pharmacies - Market size and forecast 2022-2027
o Exhibit 63: Chart on Hospital pharmacies - Market size and forecast 2022-2027 ($ billion)
o Exhibit 64: Data Table on Hospital pharmacies - Market size and forecast 2022-2027 ($ billion)
o Exhibit 65: Chart on Hospital pharmacies - Year-over-year growth 2022-2027 (%)
o Exhibit 66: Data Table on Hospital pharmacies - Year-over-year growth 2022-2027 (%)
o 7.5 Online pharmacies - Market size and forecast 2022-2027
o Exhibit 67: Chart on Online pharmacies - Market size and forecast 2022-2027 ($ billion)
o Exhibit 68: Data Table on Online pharmacies - Market size and forecast 2022-2027 ($ billion)
o Exhibit 69: Chart on Online pharmacies - Year-over-year growth 2022-2027 (%)
o Exhibit 70: Data Table on Online pharmacies - Year-over-year growth 2022-2027 (%)
o 7.6 Market opportunity by Distribution Channel
o Exhibit 71: Market opportunity by Distribution Channel ($ billion)
• 8 Customer Landscape
o 8.1 Customer landscape overview
o Exhibit 72: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 9 Geographic Landscape
o 9.1 Geographic segmentation
o Exhibit 73: Chart on Market share by geography 2022-2027 (%)
o Exhibit 74: Data Table on Market share by geography 2022-2027 (%)
o 9.2 Geographic comparison
o Exhibit 75: Chart on Geographic comparison
o Exhibit 76: Data Table on Geographic comparison
o 9.3 North America - Market size and forecast 2022-2027
o Exhibit 77: Chart on North America - Market size and forecast 2022-2027 ($ billion)
o Exhibit 78: Data Table on North America - Market size and forecast 2022-2027 ($ billion)
o Exhibit 79: Chart on North America - Year-over-year growth 2022-2027 (%)
o Exhibit 80: Data Table on North America - Year-over-year growth 2022-2027 (%)
o 9.4 Europe - Market size and forecast 2022-2027
o Exhibit 81: Chart on Europe - Market size and forecast 2022-2027 ($ billion)
o Exhibit 82: Data Table on Europe - Market size and forecast 2022-2027 ($ billion)
o Exhibit 83: Chart on Europe - Year-over-year growth 2022-2027 (%)
o Exhibit 84: Data Table on Europe - Year-over-year growth 2022-2027 (%)
o 9.5 Asia - Market size and forecast 2022-2027
o Exhibit 85: Chart on Asia - Market size and forecast 2022-2027 ($ billion)
o Exhibit 86: Data Table on Asia - Market size and forecast 2022-2027 ($ billion)
o Exhibit 87: Chart on Asia - Year-over-year growth 2022-2027 (%)
o Exhibit 88: Data Table on Asia - Year-over-year growth 2022-2027 (%)
o 9.6 Rest of World (ROW) - Market size and forecast 2022-2027
o Exhibit 89: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion)
o Exhibit 90: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion)
o Exhibit 91: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
o Exhibit 92: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
o 9.7 US - Market size and forecast 2022-2027
o Exhibit 93: Chart on US - Market size and forecast 2022-2027 ($ billion)
o Exhibit 94: Data Table on US - Market size and forecast 2022-2027 ($ billion)
o Exhibit 95: Chart on US - Year-over-year growth 2022-2027 (%)
o Exhibit 96: Data Table on US - Year-over-year growth 2022-2027 (%)
o 9.8 Germany - Market size and forecast 2022-2027
o Exhibit 97: Chart on Germany - Market size and forecast 2022-2027 ($ billion)
o Exhibit 98: Data Table on Germany - Market size and forecast 2022-2027 ($ billion)
o Exhibit 99: Chart on Germany - Year-over-year growth 2022-2027 (%)
o Exhibit 100: Data Table on Germany - Year-over-year growth 2022-2027 (%)
o 9.9 China - Market size and forecast 2022-2027
o Exhibit 101: Chart on China - Market size and forecast 2022-2027 ($ billion)
o Exhibit 102: Data Table on China - Market size and forecast 2022-2027 ($ billion)
o Exhibit 103: Chart on China - Year-over-year growth 2022-2027 (%)
o Exhibit 104: Data Table on China - Year-over-year growth 2022-2027 (%)
o 9.10 UK - Market size and forecast 2022-2027
o Exhibit 105: Chart on UK - Market size and forecast 2022-2027 ($ billion)
o Exhibit 106: Data Table on UK - Market size and forecast 2022-2027 ($ billion)
o Exhibit 107: Chart on UK - Year-over-year growth 2022-2027 (%)
o Exhibit 108: Data Table on UK - Year-over-year growth 2022-2027 (%)
o 9.11 India - Market size and forecast 2022-2027
o Exhibit 109: Chart on India - Market size and forecast 2022-2027 ($ billion)
o Exhibit 110: Data Table on India - Market size and forecast 2022-2027 ($ billion)
o Exhibit 111: Chart on India - Year-over-year growth 2022-2027 (%)
o Exhibit 112: Data Table on India - Year-over-year growth 2022-2027 (%)
o 9.12 Market opportunity by geography
o Exhibit 113: Market opportunity by geography ($ billion)
• 10 Drivers, Challenges, and Trends
o 10.1 Market drivers
o 10.2 Market challenges
o 10.3 Impact of drivers and challenges
o Exhibit 114: Impact of drivers and challenges in 2022 and 2027
o 10.4 Market trends
• 11 Vendor Landscape
o 11.1 Overview
o 11.2 Vendor landscape
o Exhibit 115: Overview on Criticality of inputs and Factors of differentiation
o 11.3 Landscape disruption
o Exhibit 116: Overview on factors of disruption
o 11.4 Industry risks
o Exhibit 117: Impact of key risks on business
• 12 Vendor Analysis
o 12.1 Vendors covered
o Exhibit 118: Vendors covered
o 12.2 Market positioning of vendors
o Exhibit 119: Matrix on vendor position and classification
o 12.3 Amgen Inc.
o Exhibit 120: Amgen Inc. - Overview
o Exhibit 121: Amgen Inc. - Product / Service
o Exhibit 122: Amgen Inc. - Key offerings
o 12.4 AstraZeneca Plc
o Exhibit 123: AstraZeneca Plc - Overview
o Exhibit 124: AstraZeneca Plc - Product / Service
o Exhibit 125: AstraZeneca Plc - Key news
o Exhibit 126: AstraZeneca Plc - Key offerings
o 12.5 Biocon Ltd.
o Exhibit 127: Biocon Ltd. - Overview
o Exhibit 128: Biocon Ltd. - Business segments
o Exhibit 129: Biocon Ltd. - Key offerings
o Exhibit 130: Biocon Ltd. - Segment focus
o 12.6 Boehringer Ingelheim International GmbH
o Exhibit 131: Boehringer Ingelheim International GmbH - Overview
o Exhibit 132: Boehringer Ingelheim International GmbH - Business segments
o Exhibit 133: Boehringer Ingelheim International GmbH - Key news
o Exhibit 134: Boehringer Ingelheim International GmbH - Key offerings
o Exhibit 135: Boehringer Ingelheim International GmbH - Segment focus
o 12.7 Cadila Pharmaceuticals Ltd.
o Exhibit 136: Cadila Pharmaceuticals Ltd. - Overview
o Exhibit 137: Cadila Pharmaceuticals Ltd. - Product / Service
o Exhibit 138: Cadila Pharmaceuticals Ltd. - Key offerings
o 12.8 Daiichi Sankyo Co. Ltd.
o Exhibit 139: Daiichi Sankyo Co. Ltd. - Overview
o Exhibit 140: Daiichi Sankyo Co. Ltd. - Business segments
o Exhibit 141: Daiichi Sankyo Co. Ltd. - Key news
o Exhibit 142: Daiichi Sankyo Co. Ltd. - Key offerings
o Exhibit 143: Daiichi Sankyo Co. Ltd. - Segment focus
o 12.9 Eli Lilly and Co.
o Exhibit 144: Eli Lilly and Co. - Overview
o Exhibit 145: Eli Lilly and Co. - Product / Service
o Exhibit 146: Eli Lilly and Co. - Key offerings
o 12.10 Glenmark Pharmaceuticals Ltd.
o Exhibit 147: Glenmark Pharmaceuticals Ltd. - Overview
o Exhibit 148: Glenmark Pharmaceuticals Ltd. - Product / Service
o Exhibit 149: Glenmark Pharmaceuticals Ltd. - Key offerings
o 12.11 Merck KGaA
o Exhibit 150: Merck KGaA - Overview
o Exhibit 151: Merck KGaA - Business segments
o Exhibit 152: Merck KGaA - Key news
o Exhibit 153: Merck KGaA - Key offerings
o Exhibit 154: Merck KGaA - Segment focus
o 12.12 Novartis AG
o Exhibit 155: Novartis AG - Overview
o Exhibit 156: Novartis AG - Business segments
o Exhibit 157: Novartis AG - Key offerings
o Exhibit 158: Novartis AG - Segment focus
o 12.13 Novo Nordisk AS
o Exhibit 159: Novo Nordisk AS - Overview
o Exhibit 160: Novo Nordisk AS - Business segments
o Exhibit 161: Novo Nordisk AS - Key offerings
o Exhibit 162: Novo Nordisk AS - Segment focus
o 12.14 Pfizer Inc.
o Exhibit 163: Pfizer Inc. - Overview
o Exhibit 164: Pfizer Inc. - Product / Service
o Exhibit 165: Pfizer Inc. - Key news
o Exhibit 166: Pfizer Inc. - Key offerings
o 12.15 Sanofi SA
o Exhibit 167: Sanofi SA - Overview
o Exhibit 168: Sanofi SA - Business segments
o Exhibit 169: Sanofi SA - Key news
o Exhibit 170: Sanofi SA - Key offerings
o Exhibit 171: Sanofi SA - Segment focus
o 12.16 Takeda Pharmaceutical Co. Ltd.
o Exhibit 172: Takeda Pharmaceutical Co. Ltd. - Overview
o Exhibit 173: Takeda Pharmaceutical Co. Ltd. - Product / Service
o Exhibit 174: Takeda Pharmaceutical Co. Ltd. - Key news
o Exhibit 175: Takeda Pharmaceutical Co. Ltd. - Key offerings
o 12.17 Tonghua Dongbao Pharmaceutical Co. Ltd.
o Exhibit 176: Tonghua Dongbao Pharmaceutical Co. Ltd. - Overview
o Exhibit 177: Tonghua Dongbao Pharmaceutical Co. Ltd. - Product / Service
o Exhibit 178: Tonghua Dongbao Pharmaceutical Co. Ltd. - Key offerings
• 13 Appendix
o 13.1 Scope of the report
o 13.2 Inclusions and exclusions checklist
o Exhibit 179: Inclusions checklist
o Exhibit 180: Exclusions checklist
o 13.3 Currency conversion rates for US$
o Exhibit 181: Currency conversion rates for US$
o 13.4 Research methodology
o Exhibit 182: Research methodology
o Exhibit 183: Validation techniques employed for market sizing
o Exhibit 184: Information sources
o 13.5 List of abbreviations
o Exhibit 185: List of abbreviations


Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market by Geography
Exhibits5: Executive Summary - Chart on Market Segmentation by Drug Class
Exhibits6: Executive Summary - Chart on Market Segmentation by Distribution Channel
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global - Market size and forecast 2022-2027 ($ billion)
Exhibits15: Data Table on Global - Market size and forecast 2022-2027 ($ billion)
Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits18: Historic Market Size - Data Table on Global type 2 diabetes market 2017 - 2021 ($ billion)
Exhibits19: Historic Market Size - Drug class Segment 2017 - 2021 ($ billion)
Exhibits20: Historic Market Size - Distribution channel Segment 2017 - 2021 ($ billion)
Exhibits21: Historic Market Size - Geography Segment 2017 - 2021 ($ billion)
Exhibits22: Historic Market Size - Country Segment 2017 - 2021 ($ billion)
Exhibits23: Five forces analysis - Comparison between 2022 and 2027
Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
Exhibits25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
Exhibits26: Threat of new entrants - Impact of key factors in 2022 and 2027
Exhibits27: Threat of substitutes - Impact of key factors in 2022 and 2027
Exhibits28: Threat of rivalry - Impact of key factors in 2022 and 2027
Exhibits29: Chart on Market condition - Five forces 2022 and 2027
Exhibits30: Chart on Drug Class - Market share 2022-2027 (%)
Exhibits31: Data Table on Drug Class - Market share 2022-2027 (%)
Exhibits32: Chart on Comparison by Drug Class
Exhibits33: Data Table on Comparison by Drug Class
Exhibits34: Chart on Insulin - Market size and forecast 2022-2027 ($ billion)
Exhibits35: Data Table on Insulin - Market size and forecast 2022-2027 ($ billion)
Exhibits36: Chart on Insulin - Year-over-year growth 2022-2027 (%)
Exhibits37: Data Table on Insulin - Year-over-year growth 2022-2027 (%)
Exhibits38: Chart on DPP-4 inhibitor - Market size and forecast 2022-2027 ($ billion)
Exhibits39: Data Table on DPP-4 inhibitor - Market size and forecast 2022-2027 ($ billion)
Exhibits40: Chart on DPP-4 inhibitor - Year-over-year growth 2022-2027 (%)
Exhibits41: Data Table on DPP-4 inhibitor - Year-over-year growth 2022-2027 (%)
Exhibits42: Chart on GLP-1 receptor agonists - Market size and forecast 2022-2027 ($ billion)
Exhibits43: Data Table on GLP-1 receptor agonists - Market size and forecast 2022-2027 ($ billion)
Exhibits44: Chart on GLP-1 receptor agonists - Year-over-year growth 2022-2027 (%)
Exhibits45: Data Table on GLP-1 receptor agonists - Year-over-year growth 2022-2027 (%)
Exhibits46: Chart on SGLT-2 inhibitors - Market size and forecast 2022-2027 ($ billion)
Exhibits47: Data Table on SGLT-2 inhibitors - Market size and forecast 2022-2027 ($ billion)
Exhibits48: Chart on SGLT-2 inhibitors - Year-over-year growth 2022-2027 (%)
Exhibits49: Data Table on SGLT-2 inhibitors - Year-over-year growth 2022-2027 (%)
Exhibits50: Chart on Others - Market size and forecast 2022-2027 ($ billion)
Exhibits51: Data Table on Others - Market size and forecast 2022-2027 ($ billion)
Exhibits52: Chart on Others - Year-over-year growth 2022-2027 (%)
Exhibits53: Data Table on Others - Year-over-year growth 2022-2027 (%)
Exhibits54: Market opportunity by Drug Class ($ billion)
Exhibits55: Chart on Distribution Channel - Market share 2022-2027 (%)
Exhibits56: Data Table on Distribution Channel - Market share 2022-2027 (%)
Exhibits57: Chart on Comparison by Distribution Channel
Exhibits58: Data Table on Comparison by Distribution Channel
Exhibits59: Chart on Retail pharmacies - Market size and forecast 2022-2027 ($ billion)
Exhibits60: Data Table on Retail pharmacies - Market size and forecast 2022-2027 ($ billion)
Exhibits61: Chart on Retail pharmacies - Year-over-year growth 2022-2027 (%)
Exhibits62: Data Table on Retail pharmacies - Year-over-year growth 2022-2027 (%)
Exhibits63: Chart on Hospital pharmacies - Market size and forecast 2022-2027 ($ billion)
Exhibits64: Data Table on Hospital pharmacies - Market size and forecast 2022-2027 ($ billion)
Exhibits65: Chart on Hospital pharmacies - Year-over-year growth 2022-2027 (%)
Exhibits66: Data Table on Hospital pharmacies - Year-over-year growth 2022-2027 (%)
Exhibits67: Chart on Online pharmacies - Market size and forecast 2022-2027 ($ billion)
Exhibits68: Data Table on Online pharmacies - Market size and forecast 2022-2027 ($ billion)
Exhibits69: Chart on Online pharmacies - Year-over-year growth 2022-2027 (%)
Exhibits70: Data Table on Online pharmacies - Year-over-year growth 2022-2027 (%)
Exhibits71: Market opportunity by Distribution Channel ($ billion)
Exhibits72: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits73: Chart on Market share by geography 2022-2027 (%)
Exhibits74: Data Table on Market share by geography 2022-2027 (%)
Exhibits75: Chart on Geographic comparison
Exhibits76: Data Table on Geographic comparison
Exhibits77: Chart on North America - Market size and forecast 2022-2027 ($ billion)
Exhibits78: Data Table on North America - Market size and forecast 2022-2027 ($ billion)
Exhibits79: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibits80: Data Table on North America - Year-over-year growth 2022-2027 (%)
Exhibits81: Chart on Europe - Market size and forecast 2022-2027 ($ billion)
Exhibits82: Data Table on Europe - Market size and forecast 2022-2027 ($ billion)
Exhibits83: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibits84: Data Table on Europe - Year-over-year growth 2022-2027 (%)
Exhibits85: Chart on Asia - Market size and forecast 2022-2027 ($ billion)
Exhibits86: Data Table on Asia - Market size and forecast 2022-2027 ($ billion)
Exhibits87: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibits88: Data Table on Asia - Year-over-year growth 2022-2027 (%)
Exhibits89: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion)
Exhibits90: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion)
Exhibits91: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits92: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits93: Chart on US - Market size and forecast 2022-2027 ($ billion)
Exhibits94: Data Table on US - Market size and forecast 2022-2027 ($ billion)
Exhibits95: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibits96: Data Table on US - Year-over-year growth 2022-2027 (%)
Exhibits97: Chart on Germany - Market size and forecast 2022-2027 ($ billion)
Exhibits98: Data Table on Germany - Market size and forecast 2022-2027 ($ billion)
Exhibits99: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibits100: Data Table on Germany - Year-over-year growth 2022-2027 (%)
Exhibits101: Chart on China - Market size and forecast 2022-2027 ($ billion)
Exhibits102: Data Table on China - Market size and forecast 2022-2027 ($ billion)
Exhibits103: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibits104: Data Table on China - Year-over-year growth 2022-2027 (%)
Exhibits105: Chart on UK - Market size and forecast 2022-2027 ($ billion)
Exhibits106: Data Table on UK - Market size and forecast 2022-2027 ($ billion)
Exhibits107: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibits108: Data Table on UK - Year-over-year growth 2022-2027 (%)
Exhibits109: Chart on India - Market size and forecast 2022-2027 ($ billion)
Exhibits110: Data Table on India - Market size and forecast 2022-2027 ($ billion)
Exhibits111: Chart on India - Year-over-year growth 2022-2027 (%)
Exhibits112: Data Table on India - Year-over-year growth 2022-2027 (%)
Exhibits113: Market opportunity by geography ($ billion)
Exhibits114: Impact of drivers and challenges in 2022 and 2027
Exhibits115: Overview on Criticality of inputs and Factors of differentiation
Exhibits116: Overview on factors of disruption
Exhibits117: Impact of key risks on business
Exhibits118: Vendors covered
Exhibits119: Matrix on vendor position and classification
Exhibits120: Amgen Inc. - Overview
Exhibits121: Amgen Inc. - Product / Service
Exhibits122: Amgen Inc. - Key offerings
Exhibits123: AstraZeneca Plc - Overview
Exhibits124: AstraZeneca Plc - Product / Service
Exhibits125: AstraZeneca Plc - Key news
Exhibits126: AstraZeneca Plc - Key offerings
Exhibits127: Biocon Ltd. - Overview
Exhibits128: Biocon Ltd. - Business segments
Exhibits129: Biocon Ltd. - Key offerings
Exhibits130: Biocon Ltd. - Segment focus
Exhibits131: Boehringer Ingelheim International GmbH - Overview
Exhibits132: Boehringer Ingelheim International GmbH - Business segments
Exhibits133: Boehringer Ingelheim International GmbH - Key news
Exhibits134: Boehringer Ingelheim International GmbH - Key offerings
Exhibits135: Boehringer Ingelheim International GmbH - Segment focus
Exhibits136: Cadila Pharmaceuticals Ltd. - Overview
Exhibits137: Cadila Pharmaceuticals Ltd. - Product / Service
Exhibits138: Cadila Pharmaceuticals Ltd. - Key offerings
Exhibits139: Daiichi Sankyo Co. Ltd. - Overview
Exhibits140: Daiichi Sankyo Co. Ltd. - Business segments
Exhibits141: Daiichi Sankyo Co. Ltd. - Key news
Exhibits142: Daiichi Sankyo Co. Ltd. - Key offerings
Exhibits143: Daiichi Sankyo Co. Ltd. - Segment focus
Exhibits144: Eli Lilly and Co. - Overview
Exhibits145: Eli Lilly and Co. - Product / Service
Exhibits146: Eli Lilly and Co. - Key offerings
Exhibits147: Glenmark Pharmaceuticals Ltd. - Overview
Exhibits148: Glenmark Pharmaceuticals Ltd. - Product / Service
Exhibits149: Glenmark Pharmaceuticals Ltd. - Key offerings
Exhibits150: Merck KGaA - Overview
Exhibits151: Merck KGaA - Business segments
Exhibits152: Merck KGaA - Key news
Exhibits153: Merck KGaA - Key offerings
Exhibits154: Merck KGaA - Segment focus
Exhibits155: Novartis AG - Overview
Exhibits156: Novartis AG - Business segments
Exhibits157: Novartis AG - Key offerings
Exhibits158: Novartis AG - Segment focus
Exhibits159: Novo Nordisk AS - Overview
Exhibits160: Novo Nordisk AS - Business segments
Exhibits161: Novo Nordisk AS - Key offerings
Exhibits162: Novo Nordisk AS - Segment focus
Exhibits163: Pfizer Inc. - Overview
Exhibits164: Pfizer Inc. - Product / Service
Exhibits165: Pfizer Inc. - Key news
Exhibits166: Pfizer Inc. - Key offerings
Exhibits167: Sanofi SA - Overview
Exhibits168: Sanofi SA - Business segments
Exhibits169: Sanofi SA - Key news
Exhibits170: Sanofi SA - Key offerings
Exhibits171: Sanofi SA - Segment focus
Exhibits172: Takeda Pharmaceutical Co. Ltd. - Overview
Exhibits173: Takeda Pharmaceutical Co. Ltd. - Product / Service
Exhibits174: Takeda Pharmaceutical Co. Ltd. - Key news
Exhibits175: Takeda Pharmaceutical Co. Ltd. - Key offerings
Exhibits176: Tonghua Dongbao Pharmaceutical Co. Ltd. - Overview
Exhibits177: Tonghua Dongbao Pharmaceutical Co. Ltd. - Product / Service
Exhibits178: Tonghua Dongbao Pharmaceutical Co. Ltd. - Key offerings
Exhibits179: Inclusions checklist
Exhibits180: Exclusions checklist
Exhibits181: Currency conversion rates for US$
Exhibits182: Research methodology
Exhibits183: Validation techniques employed for market sizing
Exhibits184: Information sources
Exhibits185: List of abbreviations